FindTrial
Sign In

Prospective study of dexmedetomidine for reducing inflammation and pain in patients following total laparoscopic hysterectomy.

Effects of dexmedetomidine on inflammation and analgesia in patients undergoing laparoscopic hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003684
Enrollment
100
Registered
2019-03-28
Start date
2019-03-22
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Bundang CHA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Korean patients of American Society of Anesthesiologists’ physical status 1 or 2 undergoing elective laparoscopic hysterectomy; age of 19-65 years; BMI < 30 kg/m2; taken informed consent approved by International Review Board.

Exclusion criteria

Exclusion criteria: who have allergy with study drugs; heart, lung, kidney, cerebrovascular, or psychiatric disease; sinus bradycardia; inability to express pain; chronic pelvic pain; chronic use of opioids; pregnancy or breast-feeding; diabetes mellitus; infection (fever within 1 week); conversion to open surgery; co-operation; Adults of American Society of Anesthesiologists’ physical status 3 or more

Design outcomes

Primary

MeasureTime frame
pain score;inflammatory response—

Secondary

MeasureTime frame
postoperative nausea and vomiting;vital signs during operation—

Countries

Korea, Republic of

Contacts

Public ContactJiyoung Lee

Bundang CHA General Hospital

leejiyoung0616@gmail.com+82-31-780-1838

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026